Binocular vision gene identified

Article

Researchers have identified the gene responsible for binocular vision.

Researchers have identified the gene responsible for binocular vision, according to a report published in the September issue of the Public Library of Science Biology.

Research conducted by Catherine Leamey from the Bosch Institute and School of Medical Sciences, Sydney, Australia and colleagues in the USA and Germany has found that a novel gene is necessary for binocular vision, allowing us to perceive depth and carry out detailed visual processing. It was discovered that the genes Ten_m3 and Bcl6 have a key role in the early development of brain pathways for vision and touch.

The gene Ten_m3, seems to be essential in order for the brain to make sense of disparate images from each eye. Projections were mismatched in the brains of mice without the gene and, because each eye's projection suppresses the other, the mice were essentially blind, despite their eyes working normally. When the output of one eye was blocked at a molecular level, the mice could see again, though only with monocular vision.

The authors of the study believe that the gene plays a critical role in visual conditions in which, by simply closing one eye, a patient is able to see better.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.